\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

SEC Filings

Trovagene is publicly traded on the NASDAQ stock exchange under the symbol CRDF.

CRDF
FormDescriptionDateFormat
10-12G/AAmendment to a previously filed 10-12GDec 30, 2011Open Amendment to a previously filed 10-12G in HTML.Open Amendment to a previously filed 10-12G in DOC file.Open Amendment to a previously filed 10-12G in PDF file.Open Amendment to a previously filed 10-12G in XLS file.
UPLOADCorrespondence from the SEC to the FilerNov 30, 2011Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
CORRESPCorrespondence from the Filer to the SECNov 25, 2011Open Correspondence from the Filer to the SEC in HTML.Open Correspondence from the Filer to the SEC in DOC file.Open Correspondence from the Filer to the SEC in PDF file.Open Correspondence from the Filer to the SEC in XLS file.
10-12GA general registration filing of securities pursuant to section 12(g) of the Securities Exchange ActNov 25, 2011Open A general registration filing of securities pursuant to section 12(g) of the Securities Exchange Act in HTML.Open A general registration filing of securities pursuant to section 12(g) of the Securities Exchange Act in DOC file.Open A general registration filing of securities pursuant to section 12(g) of the Securities Exchange Act in PDF file.Open A general registration filing of securities pursuant to section 12(g) of the Securities Exchange Act in XLS file.